Cargando…

A systematic review on hydroxyurea therapy for sickle cell disease in India

BACKGROUND & OBJECTIVES: Sickle cell disease (SCD) constitutes frequently inherited haemoglobin disorders and poses a significant health burden in India. Hydroxyurea (HU), the most commonly used drug, has shown promising results in the clinical management of SCD. The present systematic review wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandey, Apoorva, Kaur, Harpreet, Borah, Sapan, Khargekar, Naveen, Karra, Vijay Kumar, Adhikari, Tulsi, Jain, Dipty, Madkaikar, Manisha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Practice: Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057355/ https://www.ncbi.nlm.nih.gov/pubmed/36629190 http://dx.doi.org/10.4103/ijmr.ijmr_3447_21

Ejemplares similares

NBSP: an online centralized database management system for a newborn sickle cell program in India
por: Pandey, Apoorva, et al.
Publicado: (2023)

Assessing engagement of scheduled tribe communities in the functioning of Village Health Sanitation & Nutrition Committees in India
por: Pandey, Apoorva, et al.
Publicado: (2022)

Chronic Hepatitis B and Related Liver Diseases Are Associated with Reduced 25-Hydroxy-Vitamin D Levels: A Systematic Review and Meta-Analysis
por: Banerjee, Anindita, et al.
Publicado: (2023)

Effectiveness of Pharmacokinetic-Guided Hydroxyurea Dose Individualization in Patients with Sickle Cell Anemia: A Mini-Review
por: dos Santos Neres, Joelma Santana, et al.
Publicado: (2023)

A systematic review of community-based studies on mental health issues among tribal populations in India
por: Verma, Priyanka, et al.
Publicado: (2022)

Comparative study of clinical features and vaccination status in Omicron and non-Omicron infected patients during the third wave in Mumbai, India
por: Takke, Apurva, et al.
Publicado: (2022)

Hydroxyurea Treatment for Sickle Cell Disease
por: Steinberg, Martin H.
Publicado: (2002)

Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease
por: Pandey, Akancha, et al.
Publicado: (2022)

Effective control of sickle cell disease with hydroxyurea therapy
por: Singh, Harminder, et al.
Publicado: (2010)

Leveraging mathematical modeling to analyze nonadherence for hydroxyurea therapy in sickle cell disease
por: Pandey, Akancha, et al.
Publicado: (2023)

Homozygous sickle cell disease in Central India & Jamaica: A comparison of newborn cohorts
por: Jain, Dipty, et al.
Publicado: (2020)

Sickle cell disease: Progress made & challenges ahead
por: Odame, Isaac, et al.
Publicado: (2020)

Hydroxyurea and sickle cell anemia: effect on quality of life
por: Ballas, Samir K, et al.
Publicado: (2006)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
por: Torres, Lidiane de Souza, et al.
Publicado: (2012)

Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
por: de Oliveira, Emanuel Almeida Moreira, et al.
Publicado: (2019)

ENHANCE—(Electronic Hydroxyurea Adherence): A Protocol to Increase Hydroxyurea Adherence in Patients with Sickle Cell Disease
por: Creary, Susan, et al.
Publicado: (2016)

Sickle Cell Disease and Pregnancy
por: Jain, Dipty, et al.
Publicado: (2019)

Pure Erythroid Leukemia in a Sickle Cell Patient Treated with Hydroxyurea
por: Yadav, Dhiraj Kumar, et al.
Publicado: (2020)

Poliovirus surveillance in patients with primary immunodeficiencies, India
por: Mohanty, Madhu Chhanda, et al.
Publicado: (2023)

Neonatal Screening and the Clinical Outcome in Children with Sickle Cell Disease in Central India
por: Upadhye, Dipti S., et al.
Publicado: (2016)

The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea
por: da Silva, Luiz Bernardino Lima, et al.
Publicado: (2012)

Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia"
por: van Beers, Eduard Johannes, et al.
Publicado: (2012)

Emerging Science of Hydroxyurea Therapy for Pediatric Sickle Cell Disease
por: Green, Nancy S., et al.
Publicado: (2013)

Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia
por: Keikhaei, Bijan, et al.
Publicado: (2016)

Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease
por: Wong, Trisha E., et al.
Publicado: (2021)

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
por: Kabuyi, Paul Lumbala, et al.
Publicado: (2023)

Implementation of Early Detection Services for Cancer in India During COVID-19 Pandemic
por: Khanna, Divya, et al.
Publicado: (2020)

Comment on "The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea"
por: Souza, José Carlos, et al.
Publicado: (2012)

Normative data for paediatric lymphocyte subsets: A pilot study from western India
por: Jodhawat, Neha, et al.
Publicado: (2023)

Genetic and biochemical markers of hydroxyurea therapeutic response in sickle cell anemia
por: Silva, Danilo Grunig Humberto, et al.
Publicado: (2013)

Improving routine outpatient monitoring for patients with sickle-cell disease on hydroxyurea
por: Ward, Joel, et al.
Publicado: (2018)

Optimizing Hydroxyurea Treatment for Sickle Cell Disease Patients: The Pharmacokinetic Approach
por: Nazon, Charlotte, et al.
Publicado: (2019)

Menopause in Brazilian women with sickle cell anemia with and without hydroxyurea therapy
por: Queiroz, Ana Mach, et al.
Publicado: (2021)

Intensive hydroxyurea dosing in very young children with sickle cell anemia
por: Wang, Winfred C., et al.
Publicado: (2023)

Impact of hydroxyurea on hospital stay & analgesic utilization in sickle cell anaemia with vaso-occlusive crises
por: Soren, Uttam Kumar, et al.
Publicado: (2022)

Morbidity pattern in hospitalized under five children with sickle cell disease
por: Jain, Dipty, et al.
Publicado: (2013)

Knowledge, attitude, and practice about cervical cancer and its screening among community healthcare workers of Varanasi district, Uttar Pradesh, India
por: Khanna, Divya, et al.
Publicado: (2019)

P109: CLINICAL CATEGORIZATION OF CHILDREN WITH SICKLE CELL DISEASE USING SEVERITY SCORE AT A TERTIARY CARE CENTER
por: Dipty Jain, L, et al.
Publicado: (2022)

Hydroxyurea Use and Hospitalization Trends in a Comprehensive Pediatric Sickle Cell Program
por: Nottage, Kerri A., et al.
Publicado: (2013)

Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countries
por: Mulaku, Mercy, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_otsup6c3l2k12511m0hobvbqak